@FiercePharma: NICE backs Astellas' Xtandi in pre-chemo patients, but J&J's Zytiga isn't so lucky. More | Follow @FiercePharma
@EricPFierce: #Sun #Pharma to launch generic Gleevec Feb. 1 but has said it won't be #manufacturing it at troubled Halol plant. Story | Follow @EricPFierce
@CarlyHFierce: Horizon shells out $510 million for access to gout med Kyrstexxa. News | Follow @CarlyHFierce
> The U.K.'s cost watchdogs have recommended NHS use of Novartis' ($NVS) Entresto for a subset of heart failure patients whose hearts are particularly poor at pumping blood. Release
> Novo Nordisk ($NVO) is teaming up with IBM to develop a digital platform for helping diabetics and their doctors manage their illness. Report
> Bayer says it has its eye on becoming a major oncology player. Report
Medical Device News
@FierceMedDev: Bloomberg: Embattled Theranos CEO continues to beat the 'transparency' drum. More | Follow @FierceMedDev
@EmilyWFierce: Novian Health reveals positive study results for breast cancer laser ablation device. Article | Follow @EmilyWFierce
> Medtronic, Samsung partner to develop neuromodulation implant apps for smart devices. Story
> Lab experts lash out at FDA move to beef up regulation of lab-developed tests. News
Biotech News
@FierceBiotech: AstraZeneca bets on the future of the 'secretome,' joining a $100M research effort. Story | Follow @FierceBiotech
@JohnCFierce: If @woodfordfunds didn't know about the questions circulating around $NWBO, you have to wonder if the DC vax thing came up for review. | Follow @JohnCFierce
@DamianFierce: A lot of culturally embarrassing quotes in this, but reporters calling 5% "an obscure black movement" is as damning as anything Shkreli says. | Follow @DamianFierce
> Wellcome invests $38M in another gene therapy startup, targeting hemophilia. News
> Otonomy wins FDA approval for a first-of-its-kind ear treatment. Article
And Finally... U.S. sales of antibiotics for use in food animals rose 23% between 2009 and 2014, federal regulators say, fueling antibiotic-resistant bacteria concerns. Report